Warfarin genotyping reduces adverse events


Genetic testing can improve the safety of warfarin therapy for patients at high risk of VTE following hip or knee replacement surgery a new study has found. The findings from the trial known as GIFT (Genetics Informatics Trial of Warfarin to Prevent Deep Venous Thrombosis), could see use of genotype-guided warfarin dosing become more widespread, ...


Already a member? Login to keep reading


OR
© 2017 the limbic